Prof. Zeng Qingjun | Gastrointestinal Tumors | Best Researcher Award

Prof. Zeng Qingjun | Gastrointestinal Tumors | Best Researcher Award

Yueyang Central Hospital | China

AUTHOR PROFILE

ORCID ID

📚EARLY ACADEMIC PURSUITS 

ZENG QINGJUN completed his Master’s degree at Xiangya Medical College, Central South University, in 2010. This prestigious institution provided a strong foundation in medical education, equipping him with the skills and knowledge necessary for his future in the field of gastrointestinal surgery. His academic training allowed him to develop expertise in complex surgical techniques, laying the groundwork for his career as a clinical specialist in surgery.

⚕️PROFESSIONAL ENDEAVORS 

Since July 2010, ZENG QINGJUN has been working in the field of gastrointestinal surgery, focusing on laparoscopic techniques for treating gastric and colorectal cancers. As a chief physician, he plays a pivotal role in leading surgical teams, performing high-risk surgeries, and making critical decisions for patient care. His clinical expertise and skillful handling of over 200 laparoscopic gastric cancer surgeries and 400 laparoscopic colorectal cancer surgeries are testaments to his proficiency in minimally invasive surgical methods. His surgical outcomes have contributed significantly to improving the quality of life for cancer patients and are recognized within the medical community.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON GASTROINTESTINAL TUMORS

Dr. ZENG has dedicated much of his professional life to the development and refinement of laparoscopic surgical techniques in the treatment of gastrointestinal cancers. His research is heavily focused on advancing minimally invasive surgery, particularly in the areas of gastric cancer and colorectal cancer. Through clinical trials and innovative methodologies, he has been involved in optimizing surgical procedures to ensure better postoperative recovery, reduced complications, and more efficient treatment pathways for cancer patients.

🌍IMPACT AND INFLUENCE 

Dr. ZENG QINGJUN has made an immense impact on the practice of gastrointestinal surgery in China, particularly in the realm of laparoscopic surgery. His innovative approaches and commitment to cutting-edge techniques have influenced both local and national surgical practices. His contribution to gastric and colorectal cancer surgery has improved patient outcomes and has set new standards in the field. As a chief physician, he mentors younger surgeons and shares his expertise, ensuring the continued progress of surgical techniques.

📑ACADEMIC CITATIONS 

While detailed citation metrics are not provided, Dr. ZENG’s extensive clinical experience and research endeavors have led to his recognition in academic circles. His focus on laparoscopic techniques and cancer surgery continues to influence current and future generations of surgeons and researchers in the field. His work, particularly in gastric and colorectal cancer, has made notable contributions to medical literature and has been referenced in various academic and clinical studies.

🌱LEGACY AND FUTURE CONTRIBUTIONS 

Dr. ZENG QINGJUN’s career reflects a legacy of excellence in surgical practice and medical innovation. His pioneering work in laparoscopic surgery and cancer treatment has already set the stage for future breakthroughs in the field of gastrointestinal oncology. Looking forward, he is likely to contribute even more significantly to surgical research, possibly expanding his focus to robot-assisted surgeries, postoperative care advancements, and the integration of AI in surgical planning. His mentorship, both locally and nationally, will shape the future of surgical education and the next generation of gastrointestinal surgeons.

💼LEADERSHIP IN SURGICAL PRACTICE 

Dr. ZENG continues to hold a significant leadership role in the surgical department at his medical institution. His capacity as chief physician enables him to make high-level decisions in clinical practice, direct surgical teams, and implement best practice guidelines. His strategic leadership in gastrointestinal surgery helps to establish protocols for laparoscopic surgeries, improving surgical outcomes, and pushing the boundaries of traditional approaches.

🔗 CONCLUSION

Dr. Zeng Qingjun is a distinguished gastrointestinal surgeon whose work has significantly advanced the field of laparoscopic surgery for gastric and colorectal cancers. With over a decade of experience and hundreds of successful surgeries, his contributions have set new standards in minimally invasive surgical techniques, improving patient outcomes and recovery times. Through his leadership as chief physician, he has not only influenced clinical practices but has also become a mentor to aspiring surgeons, ensuring the continuity of high-quality surgical education.

📊🔬NOTABLE PUBLICATION:
  • 1. Title: Knockdown of BUB1B Inhibits the Proliferation, Migration, and Invasion of Colorectal Cancer by Regulating the JNK/c-Jun Signaling Pathway
    Authors: Qingjun Zeng, Sanjun Zhang, Linfang He, Qingyan Fu, Li Liao, Linjie Chen, Xiang Ding
    Journal: Cancer Biotherapy and Radiopharmaceuticals
    Year: 2023


    2. Title: Targeting of MAD2L1 by miR‐515‐5p involves the regulation of cell cycle arrest and apoptosis of colorectal cancer cells
    Authors: Xiang Ding, Qingyan Fu, Weixing Chen, Linjie Chen, Qingjun Zeng, Sanjun Zhang, Linfang He
    Journal: Cell Biology International
    Year: 2022

Dr. Jinyu Zhang | Hepatocellular Carcinoma | Best Researcher Award

Dr. Jinyu Zhang | Hepatocellular Carcinoma | Best Researcher Award

Fujian Medical University | China

AUTHOR PROFILE

Scopus

JINYU ZHANG: ACADEMIC JOURNEY AND PROFESSIONAL IMPACT

🎓EARLY ACADEMIC PURSUITS

Jinyu Zhang began their academic journey in Clinical Medicine Science at Fujian Medical University, where they pursued a rigorous undergraduate program from September 2014 to June 2019. This foundational education equipped Jinyu with a strong understanding of medical principles, diagnostics, and patient care. Their dedication to excellence during these formative years laid the groundwork for a promising career in medicine.

💼ADVANCED EDUCATION AND SPECIALIZATION

Building upon their undergraduate achievements, Jinyu Zhang pursued a Master’s degree in Surgery at Fujian Medical University from September 2019 to June 2022. This phase marked a significant transition to specialized training, allowing them to deepen their expertise in surgical techniques, patient management, and clinical research.

Currently, Jinyu is enrolled in a Doctoral program in Surgery at Fujian Medical University, which they began in September 2022. This ongoing pursuit highlights their commitment to advancing medical science and refining their clinical acumen.

🔬PROFESSIONAL ENDEAVORS

Throughout their academic career, Jinyu Zhang has shown a consistent interest in combining theoretical knowledge with practical application. Their professional endeavors include:

  • Clinical Rotations: Active participation in diverse hospital departments during their undergraduate and master’s studies to gain hands-on experience.
  • Surgical Training: Specialized focus on improving surgical outcomes and patient recovery rates.
  • Research Collaborations: Involvement in multidisciplinary projects to enhance surgical methodologies and innovate treatment strategies.

🌍CONTRIBUTIONS AND RESEARCH FOCUS ON HEPATOCELLULAR CARCINOMA

Jinyu Zhang’s research primarily focuses on:

  • Minimally Invasive Surgical Techniques: Exploring innovative approaches to reduce patient recovery time and improve procedural efficiency.
  • Post-Surgical Care Optimization: Studying ways to enhance post-operative outcomes through better patient management and intervention strategies.
  • Surgical Training and Education: Developing frameworks to improve surgical education for aspiring surgeons.

Their work bridges the gap between research and practical application, contributing to advancements in the field of surgery.

📚IMPACT AND INFLUENCE

Jinyu Zhang’s contributions to clinical medicine and surgery have started gaining recognition among peers and mentors. Their innovative ideas have the potential to shape future surgical practices and improve patient care standards. Through conference presentations and research publications, Jinyu has actively participated in disseminating knowledge to the medical community.

🔮ACADEMIC CITATIONS

Jinyu Zhang’s academic work is increasingly being cited by peers, demonstrating its relevance and impact in the field of surgery. These citations reflect the quality and applicability of their research in addressing contemporary challenges in surgical practice.

🏆LEGACY AND FUTURE CONTRIBUTIONS

As Jinyu Zhang progresses in their Doctoral studies and continues to refine their skills and research expertise, their legacy is likely to include:

  • Innovative Surgical Techniques: Introduction of new methods that could revolutionize surgical procedures.
  • Mentorship: Inspiring and guiding the next generation of medical students and researchers.
  • Collaborative Contributions: Partnering with global medical institutions to advance the field of surgery.

🌟CONCLUSION

Jinyu Zhang’s journey from a dedicated medical student to an emerging expert in surgery exemplifies a blend of academic rigor and professional ambition. Their research focus, contributions to surgical science, and commitment to patient care position them as a future leader in the field. With ongoing efforts, they are poised to leave an indelible mark on medical practice and research.

 

📊🔬NOTABLE PUBLICATION:
    1. Prognostic value and predication model of microvascular invasion in patients with intrahepatic cholangiocarcinoma: a multicenter study from China
      • Authors: Chen, Y.; Liu, H.; Zhang, J.; …; Zeng, Y.; Liu, J.
      • Journal: BMC Cancer
      • Year: 2021

    1. Development and validation of nomogram to predict very early recurrence of combined hepatocellular-cholangiocarcinoma after hepatic resection: a multi-institutional study
      • Authors: Wu, Y.; Liu, H.; Zeng, J.; …; Zeng, Y.; Liu, J.
      • Journal: World Journal of Surgical Oncology
      • Year: 2022

    1. Perioperative safety, oncologic outcome, and risk factors of salvage liver resection for initially unresectable hepatocellular carcinoma converted by transarterial chemoembolization plus tyrosine kinase inhibitor and anti-PD-1 antibody: a retrospective multicenter study of 83 patients
      • Authors: Lin, K.-Y.; Lin, Z.-W.; Chen, Q.-J.; …; Yang, T.; Zeng, Y.-Y.
      • Journal: Hepatology International
      • Year: 2023

    1. Antiviral Therapy Improves Survival in Hepatocellular Carcinoma with Microvascular Invasion: A Propensity Score Analysis
      • Authors: Kong, J.; Liang, X.; Zhang, J.; …; Liu, J.; Zeng, J.
      • Journal: Digestive Diseases and Sciences
      • Year: 2022

    1. Prognostic significance of three-tiered pathological classification for microvascular invasion in patients with combined hepatocellular-cholangiocarcinoma following hepatic resection
      • Authors: Wu, Y.; Liu, H.; Chen, Y.; …; Zeng, Y.; Liu, J.
      • Journal: Cancer Medicine
      • Year: 2023